What we have achieved

2000Volunteers recruited
250Completed trials since 1996
70Investigator Initiated Trials completed
180Industry Sponsored Trials completed

Ongoing clinical trials in IMU

Phase 4 Dengue study

Phase 4 Dengue study Study Details Ketotifen as a Treatment for Vascular Leakage during Dengue Fever. A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Clinical Trial to Evaluate the Efficacy of Ketotifen for Reducing Vascular Leakage in Dengue Protocol Number EID-DF-02 Phase IV Therapeutic Area Infectious Disease Subject Types With Medical Condition Indication Dengue Principal Investigator Dr Paul …

Phase 4 Dengue studyRead More »

Phase 3 haematology study to evaluate the safety and efficacy of ALXN1210 compared to eculizumab

Phase 3 haematology study to evaluate the safety and efficacy of ALXN1210 compared to eculizumabStudy Details This is a Phase 3, open-label, randomized, active-controlled, multicenter study to evaluate the safety and efficacy of ALXN1210 versus eculizumab administered by intravenous (IV) infusion to adult patients with PNH who are naïve to complement inhibitor treatment. Protocol Number …

Phase 3 haematology study to evaluate the safety and efficacy of ALXN1210 compared to eculizumabRead More »

Phase 2 Autism study to assess long-term efficacy of Intranasal Oxytocin and the underlying neural mechanisms

Intranasal Oxytocin for Autism Spectrum Disorder: assessing long-term efficacy and underlying neural mechanisms in a randomized controlled trial

Volunteers

Be a hero to others today!

Be part of a journey to discover new therapies to improve the future of healthcare.

Partners

Interested to work together with us?

Collaborate with IMU to discover better treatments for a better tomorrow.